Results 161 to 170 of about 40,880 (280)

HDLs in apoA-I transgenic Abca1 knockout mice are remodeled normally in plasma but are hypercatabolized by the kidney

open access: yesJournal of Lipid Research, 2005
Patients homozygous for Tangier disease have a near absence of plasma HDL as a result of mutations in ABCA1 and hypercatabolize normal HDL particles. To determine the relationship between ABCA1 expression and HDL catabolism, we investigated intravascular
Ji-Young Lee   +8 more
doaj   +1 more source

Обратный транспорт холестерина из макрофагов [PDF]

open access: yes, 2011
МАКРОФАГИХОЛЕСТЕРИ
Куликов, В. А.
core  

Delivery of human apolipoprotein (apo) E to liver by an [E1(-), E3(-), polymerase(-), pTP(-)] adenovirus vector containing a liver-specific promoter inhibits atherogenesis in immunocompetent apoE-deficient mice [PDF]

open access: yes, 2006
Recombinant adenovirus (rAd)-mediated apoE gene transfer to the liver of apoE(-/-) mice is anti-atherogenic. However, first generation rAd vectors were associated with immune clearance of transduced hepatocytes, while an improved [E1(-), E3(-) polymerase(
Amalfitano, A   +4 more
core  

Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Macrophages Increases Inflammation and Accelerates Atherosclerosis in Mice [PDF]

open access: bronze, 2013
Marit Westerterp   +15 more
openalex   +1 more source

Mechanism of ATP-binding Cassette Transporter A1-mediated Cellular Lipid Efflux to Apolipoprotein A-I and Formation of High Density Lipoprotein Particles*

open access: yesJournal of Biological Chemistry, 2007
Charulatha Vedhachalam   +8 more
semanticscholar   +1 more source

Der Einfluss der Nikotinsäure auf die Expression von PPARgamma, Scavenger Rezeptoren und ABCA-1 auf monozytoiden und hepatischen Zellen [PDF]

open access: yes, 2004
Das natürliche Vitamin Nikotinsäure wird seit 1955 in pharmakologischer Dosierung als Medikament zur Behandlung von Dyslipidämien und bei arteriosklerotischen Gefäßveränderungen verwendet.
Trottmann, Matthias
core  

MicroRNA-144 Regulates Hepatic ATP Binding Cassette Transporter A1 and Plasma High-Density Lipoprotein After Activation of the Nuclear Receptor Farnesoid X Receptor

open access: yesCirculation Research, 2013
Thomas Q. de Aguiar Vallim   +6 more
semanticscholar   +1 more source

Physiologically regulated transgenic ABCA1 does not reduce amyloid burden or amyloid‐beta peptide levels in vivo [PDF]

open access: yes, 2007
J Lipid Res. 2007 Apr;48(4):914-23. Epub 2007 Jan 18. Physiologically regulated transgenic ABCA1 does not reduce amyloid burden or amyloid-beta peptide levels in vivo.
CHAN, J.Y.   +9 more
core  

Home - About - Disclaimer - Privacy